Background: The use of biotherapies in Trypanosoma cruzi infection can provide an understanding about effects of these highly diluted medications.
Objectives: To evaluate different treatment schemes and dynamizations of biotherapies prepared from blood trypomastigotes (buffy coat) in mice infected with T. cruzi.